Takeda Pharmaceuticals U.S.A., Inc. v. Par Pharmaceuticals Companies, Inc., et al.; Takeda Pharmaceuticals U.S.A., Inc. v. Amneal Pharmaceuticals, LLC; Takeda Pharmaceuticals U.S.A., Inc. v. Watson Laboratories, Inc., C.A. Nos. 13-1524 – SLR; 13-1729 – SLR; 14-268 SLR, June 1, 2015

Robinson, J. Claim construction opinion issues regarding three disputed terms from four patents-in-suit.

The court construes the following disputed terms:

  1. After waiting 12 hours
  2. Concurrently
  3. Onset of the acute gouty arthritis attack/ onset of gout flare